Vimarsana
Biggest News Aggregation in the World

Page 2 - Daniel Elbaum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Elbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Elbaum Today - Breaking & Trending Today

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022 - Vimarsana News

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

Connection between STATHMIN-2, TDP-43, and ALS cell biology led to discovery of Company's approach and lead development candidate in ALSUpdated da...

Who Zelensky wants the Jewish people (and all of us) to be - Vimarsana News

Who Zelensky wants the Jewish people (and all of us) to be

3 pesky thoughts that get in our way of doing the right thing, and 4 'right things' to do to ensure we act well when we have our chance

Alpha Epsilon Pi honors three alumni with highest Jewish communal award - Vimarsana News

Alpha Epsilon Pi honors three alumni with highest Jewish communal award

Elan Carr, Daniel Elbaum and Honorable Ron Klein to receive the Gitelson Silver Medallion for Jewish Communal Service.

Source: jns.org
QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND - Vimarsana News

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

/PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other...

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND - Vimarsana News

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com